Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exudative complications after photodynamic therapy

Eric R Holz1, Leslie Linares, William F Mieler

  • 1Cullen Eye Institute, Baylor College of Medicine, Houston, TX 77030, USA. eholz@bcm.tmc.edu

Archives of Ophthalmology (Chicago, Ill. : 1960)
|November 12, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REPLY.

Ophthalmology·2026
Same author

Advancements and challenges in ophthalmic microneedles to treat eye diseases.

Drug delivery·2026
Same author

A simulation study of fluorescein attenuation and dynamic tracer kinetic model-extracted retinal blood flow from human retinal fluorescein videoangiographies.

Proceedings of SPIE--the International Society for Optical Engineering·2025
Same author

Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision).

Ophthalmology·2025
Same author

International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI).

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2025
Same author

Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction.

Signal transduction and targeted therapy·2025